Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk

Purpose: Proton radiotherapy (PRT) is potentially associated with a lower risk for secondary malignancies due to a decreased integral dose to the surrounding organs at risk (OARs). Prospective trials confirming this are lacking due to the need for long-term follow-up and the ethical complexities of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Laila König, Peter Haering, Clemens Lang, Mona Splinter, Bastian von Nettelbladt, Fabian Weykamp, Philipp Hoegen, Jonathan W. Lischalk, Klaus Herfarth, Jürgen Debus, Juliane Hörner-Rieber
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Frontiers Media S.A. 2020-07-01
Saila:Frontiers in Oncology
Gaiak:
mediastinal lymphoma
proton radiotherapy
intensity modulated radiotherapy
photon radiotherapy
secondary malignancies
risk
Sarrera elektronikoa:https://www.frontiersin.org/article/10.3389/fonc.2020.00989/full
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak